Benefits Pro1h
Medicaid spending on GLP-1s exceeded $3.5B in past year
California’s Medicaid program spent the most of all states on GLP-1 coverage, exceeding $1.4 billion, or $118 per enrollee.
The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be next
Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug ...
McKnight's Long-Term Care News5h
FDA approves Zepbound for sleep apnea in patients with obesity
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
The Spokesman-Review14h
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat ... which delivers air ...
Eli Lilly Stock Is Rising Monday: What's Going On?
Eli Lilly and Company (NYSE: LLY) shares are trading higher Monday. The upward momentum in the stock comes after the FDA ...
STAT2d
Vertex drug for cystic fibrosis wins approval
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Health Affairs9d
Proposed Rule Would Expand Medicare And Medicaid Coverage For Anti-Obesity Medications
Senator Bernie Sanders (I-VT), for example, stated that “unless Medicare demands that Novo Nordisk and Eli Lilly substantially reduce the prices for these anti-obesity drugs, Medicare premiums for all ...
FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea
The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...
Morningstar4d
Eli Lilly: Zepbound's Sleep Apnea Approval Differentiates from Novo Nordisk, Especially in Medicare
This could be particularly important for Medicare patients (obesity drugs are ... The bottom line: We're maintaining our $580 fair value estimate for Eli Lilly, and the firm's tirzepatide molecule ...
CBS News5d
Medicare's new $2,000 prescription drug cap goes into effect Jan. 1. Here's how it works.
Starting Jan. 1, millions of Americans who get their prescription drugs through Medicare could get a major financial break when a $2,000 out-of-pocket spending cap on medications goes into effect.
WTVD5d
FDA approves Eli Lilly's obesity medication for obstructive sleep apnea
including Medicare, do not offer reimbursement to treat obesity alone. The new approval is for people with moderate to severe obstructive sleep apnea who are also living with obesity. Eli Lilly ...